Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related mortality.
Molecular heterogeneity and absence of biomarkers for patient allocation to the best …

Hepatocellular carcinoma (HCC), the most common form of primary liver cancers, accounts
for a significant portion of cancer-related death globally. However, the molecular …

Hepatocellular carcinoma (HCC) is the major type of primary liver cancer. Genomic studies
have revealed that HCC is a heterogeneous disease with multiple subtypes. BRG1 …

MicroRNAs (miRNAs) have emerged as potential therapeutic targets for non-alcoholic fatty
liver disease/non-alcoholic steatohepatitis (NAFLD/NASH). Traditional Chineses Medicine …

Most of the human genome consists of DNA genes that are translated into RNAs but not into
proteins. These RNA molecules are named noncoding RNAs (ncRNA). While in the past it …

Biliary tract cancer is a devastating malignancy of the bile ducts and gallbladder with a
dismal prognosis. The study of precancerous lesions has received considerable attention …

Hepatocellular carcinoma (HCC) is a malignant tumor that arises from hepatocytes. Multiple
signaling pathways play a regulatory role in the occurrence and development of HCC, with …

Simple Summary Liver cancer is one of the most commonly diagnosed cancers worldwide
and the fourth leading cause of cancer-related deaths. Hepatocellular carcinoma (HCC) …

The poor prognosis of advanced hepatocellular carcinoma (HCC) is driven by diverse
features including dysregulated microRNAs inducing drug resistance and stemness. Lin-28 …

The search for new cancer treatments from traditional medicine involves developing studies
to understand at the molecular level different cell signaling pathways involved in cancer …